Influence de l’analgésie peropératoire (sufentanil administré selon les critères usuels ou rémifentanil administré par un système automatisé à partir de l’Index Bispectral) sur la consommation de morphine postopératoire (Etude monocentrique, prospective, randomisée, réalisée en simple aveugle) - Drone-Douleur

• Conditions: general anesthesia; MedDRA version: 9.1Level: LLTClassification code 10002323Term: Anesthesia general; MedDRA version: 9.1Level: LLTClassification code 10036236Term: Postoperative pain relief

• Registration Number: EUCTR2007-002978-62-FR
• Lead Sponsor: Hopital Foch

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-02-06
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients scheduled for an abdominal surgery
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- Age less than 18 years,
- Pregnant woman,
- Allergy to propofol, sufentanil, remifentanil, morphine, muscle relaxant, or to a component,
- Hypersensibility to sufentanil, remifentanil or to a derivate of fentanyl,
- Inflammatory bowel disease,
- Chronic pain,
- Patients receiving a psychotropic treatment or a a morphine agonist-antagonist,
- Alcoolic patients and patients taking opiates,
- History of neurological disorders or central brain lesion, of severe respiratory insufficiency, of hepatic insufficiency,
- Emergency surgery.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified